Clinical trial
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced…
NCT00003690 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00003690 |
|---|---|
| Title | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of Flavopiridol in Combination With Cisplatin in Patients With Advanced Malignancies |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Melanoma (Skin), Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | alvocidib, carboplatin, cisplatin |
| Enrollment | 48 |
| Start date | Dec 1, 1998 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: